DePuy in trouble after considerable profit
DePuy, the orthopedic branch of Johnson & Johnson, is facing trouble and a class action lawsuit after a major design flaw was discovered in their hip replacement devices. The irony of it all is that DePuy itself had already announced that they would discontinue the ASR hip devices that caused all this trouble, with aim on focusing on new technologies and materials instead of the metal-on-metal prosthetic. But it was exactly the material used that was the focus point of all the problems. The friction between the two parts of the hip replacement implant caused a lot of metal debris to shed inside the patients’ bodies and led to several health complications. One out of every eight patients fitted with these implants needed corrective surgery within the first five years of receiving the implant, when the average life span of one of these devices is fifteen years. And this situation has led to calls over the media and the internet for people to contact DePuy hip lawyer and join the lawsuit against the company.
This came as a shock for everyone in the financial and medical community because this didn’t happen to just any company. DePuy , being part of the Johnson & Johnson family, has a standard of quality to uphold. Its mother company, Johnson & Johnson, has for long been a symbol of quality and of consumer trust and fidelity. Now that trust seems to be slightly dented. Adding to the surprise is the shock factor of this company having turned a massive profit just last year. It goes to show that it doesn’t matter how much money you make – if you don’t keep the standards of quality high enough, you may end up losing a lot of that money anyway.